Project Grant H79FG001374

Award Date 9/30/24
Completion Date 9/29/25
Dollars Obligated $2M
Federal Grant Program
93.493
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This federal Project Grant award, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Opioid STR (CFDA 93.788) program, will provide $71,160,580 to the Wisconsin Department of Health Services (DHS) to address the opioid crisis in Wisconsin. The grant will focus on expanding access to evidence-based opioid and stimulant use disorder treatment and recovery services, advancing opioid and stimulant use prevention and harm reduction, and reducing opioid and...
The Department of Health and Human Services Health Resources and Services Administration (HRSA) awarded a $3,000,000 Rural Health Research Centers (CFDA 93.155) program grant to Core Treatment Services, Inc. in Manitowoc, Wisconsin. The grant, effective September 1, 2024 through August 31, 2028, will fund the "Rural Communities Opioid Response Program-IMPACT" project. This project aims to address the opioid epidemic in five rural Wisconsin counties by providing comprehensive treatment,...
The City of Milwaukee was awarded a $1.2 million Project Grant from the Department of Justice Office of Justice Programs Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP) to implement the Milwaukee Overdose Response Initiative from October 1, 2021 through September 30, 2024. The goal of the COSSUP program is to provide financial and technical assistance to address the opioid crisis. Through this funding, the City of Milwaukee's...
This federal Block Grant award, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Block Grants for Prevention and Treatment of Substance Abuse (CFDA 93.959) program, supports comprehensive substance abuse prevention, treatment, and rehabilitation activities across Wisconsin. The $20,887,653 award will fund a wide range of interventions, including prevention education, outpatient counseling, crisis intervention, medication-assisted treatment, recovery...
This Project Grant award of $1,300,000 from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and Substance Use Program (CFDA 16.838) will enable the City of West Allis, Wisconsin to expand access to evidence-based treatment for stimulant use disorder and harm reduction services in suburban Milwaukee County. The project, called CP-STAR, will leverage community paramedic teams to address the impact of opioids, fentanyl, and stimulants in...
The University of Wisconsin System, through its University of Wisconsin - Madison division, has been awarded a $1,042,225.00 Project Grant by the National Institute of Justice (NIJ) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP). The grant, with an award date of January 1, 2024 and an ultimate completion date of December 31, 2026, aims to develop and validate an accessible methamphetamine enantiomer-specific identification and quantification method, and...
The Stockbridge-Munsee Health and Wellness Center Opioid Response Project is a $373,449 federal grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The project aims to increase access to culturally appropriate and evidence-based opioid use disorder treatment, including medication-assisted treatment using Vivitrol, purchasing and...
This Project Grant award was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant, totaling $400,907,000, will fund the Ohio's State Opioid and Stimulant Response (SOS) 4.0 program. Key services to be delivered include: Expanding access to harm reduction, peer recovery supports, and evidence-based substance use disorder treatment, with...
The City of Milwaukee, WI was awarded a $1,598,719 Project Grant from the Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (COSSUP). The grant will support the Milwaukee Drug Rapid-Testing and Outreach Program (DROP) from October 1, 2022 to September 30, 2025. Through DROP, the City of Milwaukee will increase capacity for near-real-time substance testing at overdose scenes and within actively using populations. It...
This Project Grant award of $1,600,000 from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and Substance Use Program (CFDA 16.838) will support Hennepin County, Minnesota in three key objectives: Increase access to opioid use disorder (OUD) treatment for detained individuals, particularly those who are disproportionately African American and Native American, by hiring a dedicated sheriff's deputy to transport and escort detainees to...

This federal Project Grant award for $2,000,000.00 was provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493). The grant will fund the establishment of the Wisconsin Opioid Overdose Response Center and Pharmacy Resource Network at the University of Wisconsin-Madison.

The key objectives of this grant are to: 1) Increase patient access to evidence-based treatments for opioid use disorder and overdose through expanded community pharmacy-based services; 2) Build the capacity of pharmacies and pharmacists across Wisconsin to provide opioid misuse and overdose prevention education and resources; and 3) Develop new technologies to help pharmacists prevent overdoses from existing and emerging synthetic opioids. This multifaceted effort aims to create a sustainable, pharmacy-focused infrastructure to combat the opioid and fentanyl crisis in Wisconsin communities, including high-risk populations like military veterans. The grant performance period is from September 30, 2024 to September 29, 2025.

Generated 7/1/25, 5:09 AM